Johnson & Johnson (J&J) unit Janssen Pharmaceutical has partnered with the US Department of Health & Human Services (HHS) to speed-up the development of its investigational vaccine candidate against the new coronavirus disease, Covid-19.
Genome & Company is pleased to announce that it has entered into a clinical trial collaboration and supply agreement with Merck KGaA, Darmstadt, Germany and Pfizer Inc.
